论文部分内容阅读
目的探讨米非司酮联合不同药物用于终止瘢痕子宫中期妊娠的临床效果。方法选取本院自2010年12月~2012年12月80例瘢痕子宫中期妊娠患者随机分为观察组与参考组,观察组患者采用米非司酮联合依沙吖啶治疗,参考组患者采用米非司酮联合米索前列醇治疗,比较两组患者治疗效果、出血量、胎盘胎膜的残留物、宫缩时间及总产程。结果观察组患者治疗总有效率为90%,参考组患者治疗总有效率为85%,P>0.05,两组总有效率差异无统计学意义;两组患者出血量、胎盘胎膜的残留物差异无统计学意义(P>0.05);观察组患者宫缩时间及总产程均明显短于参考组,P<0.05,差异具有统计学意义。结论米非司酮联合依沙吖啶用于终止瘢痕子宫中期妊娠具有显著疗效,值得推广。
Objective To investigate the clinical effect of mifepristone combined with different drugs for termination of uterine scar pregnancy. Methods From December 2010 to December 2012 80 cases of uterine scar pregnancy were randomly divided into observation group and reference group, the observation group patients treated with mifepristone combined with ethacridine, the reference group of patients with rice Nifedipine combined with misoprostol treatment, the treatment effect of two groups were compared, the amount of bleeding, residual placental membranes, contractions time and total labor. Results The total effective rate was 90% in the observation group and 85% in the reference group, P> 0.05. There was no significant difference in the total effective rate between the two groups. The amount of bleeding, residual fetal membranes There was no significant difference between the two groups (P> 0.05). The time of contractions and total labor in the observation group were significantly shorter than those in the reference group (P <0.05). The difference was statistically significant. Conclusion Mifepristone combined with ethacridine has a significant effect in terminating metaphase pregnancy of uterine scar, which is worth promoting.